ACC 2021 | Emergent CABG for acute MI: Benefits Despite Risk

The latest figures show a lower number of emergency CABG for acute MI, and in turn increased primary PCI. 

ACC 2021 | Cirugía de emergencia en el infarto: beneficios a pesar del alto riesgo

The combination of surgeons not willing to take risks and interventional cardiologists empowered to treat practically any lesion has resulted in fewer patients receiving emergency CABG. Only a few years ago, interventional cardiologists at least had the “courtesy” to agree on a treatment strategy with the surgeon on call. Several years of choosing PCI over CABG have granted interventionists clearance to bypass surgeons and directly proceed to percutaneous intervention, practically in every center. 

This study presented today at ACC 2021 simultaneously published in JAHA, shows the figures behind the above statements. Comparing the years 2000 and 2017, emergency CABG saw a 90% reduction. 

It is also clear that surgical techniques and post operatory care have improved in the same period. This has contributed to keep a clear benefit in terms of mortality, despite volume reduction and case selection. 

When comparing patients undergoing surgery in the first part of the study vs the second part, some interesting information becomes clear


Read also: ACC 2021 | LAAOS III: Appendage Closure During Central Vascular Surgery.


Patients treated in the second, most recent period, were more frequently non-STEMI cases (80.5% vs 56.1%), more often presented non-cardiac multiorgan failure (26.1% vs 8.4%), presented cardiogenic shock (11.5% vs 6.4%) and received mechanical circulatory support (19.8% vs 18.7%; p< 0.001 for all comparisons). 

Despite all the above mentioned, mortality in these periods resulted similar (5.3% in 2000 vs 3.6% in 2017).

Original Title: Temporal trends, clinical characteristics and outcomes of emergent coronary artery bypass grafting for acute myocardial infarction in the United States.

Reference: Patlolla SH et al. Presentado en el congreso de la ACC 2021 y publicado simultáneamente en J Am Heart Assoc.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

FLAVOUR Trial Substudy: FFR or IVUS in the Assessment of Diabetic Patients

Patients with diabetes often present with more complex coronary artery disease compared to non-diabetic patients, with a higher prevalence of diffuse or multivessel disease....

Mechanical Circulatory Support in Complex Anatomies and Severe Deterioration of Left Ventricular Function

Severe coronary artery disease (CAD) frequently causes left ventricular function deterioration, and is often treated with myocardial revascularization surgery (CABG), especially when ejection fraction...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

TAVR Unload: TAVR in Moderate Aortic Stenosis and Ventricular Function Deterioration

Aortic Stenosis (AS) significantly contributes to valvulo-arterial impedance in patients with heart failure and reduced ejection fraction (HFrEF), making it a relevant therapeutic target...